MiMedx Correlations
| MDXG Stock | USD 6.43 0.08 1.23% |
The correlation of MiMedx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MiMedx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MiMedx Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Poor diversification
The correlation between MiMedx Group and NYA is 0.61 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MiMedx Group and NYA in the same portfolio, assuming nothing else is changed.
MiMedx |
The ability to find closely correlated positions to MiMedx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MiMedx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MiMedx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MiMedx Group to buy it.
Moving together with MiMedx Stock
| 0.9 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.67 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
| 0.68 | GILD | Gilead Sciences Earnings Call Today | PairCorr |
Moving against MiMedx Stock
| 0.87 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.76 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.74 | ELYM | Eliem Therapeutics | PairCorr |
| 0.65 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.64 | XFOR | X4 Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.42 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.85 | ACRV | Acrivon Therapeutics Financial Report 14th of May 2024 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between MiMedx Stock performing well and MiMedx Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MiMedx's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CTMX | 3.40 | 0.05 | 0.03 | 0.11 | 3.82 | 8.16 | 50.71 | |||
| ASMB | 2.58 | 0.33 | 0.10 | 0.36 | 3.30 | 6.20 | 19.82 | |||
| ACHL | 3.86 | (0.10) | 0.00 | 0.04 | 6.04 | 9.56 | 38.89 | |||
| TIL | 1.93 | 0.14 | 0.06 | 0.26 | 1.99 | 4.48 | 18.48 | |||
| NXTC | 4.34 | 0.58 | 0.10 | 1.40 | 4.85 | 8.13 | 32.17 | |||
| SPRO | 2.57 | 0.00 | 0.00 | 0.08 | 3.29 | 4.82 | 16.20 | |||
| NUVB | 4.98 | 1.06 | 0.23 | 1.21 | 3.98 | 16.67 | 46.16 | |||
| CGEM | 2.92 | 0.45 | 0.13 | 0.29 | 3.49 | 6.65 | 28.94 | |||
| BOLT | 3.16 | (0.03) | 0.00 | 0.18 | 0.00 | 6.40 | 21.42 | |||
| DAWN | 2.97 | 0.14 | 0.07 | 0.15 | 3.39 | 6.06 | 20.03 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in MiMedx without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
MiMedx Corporate Directors
MiMedx corporate directors refer to members of a MiMedx board of directors. The board of directors generally takes responsibility for the MiMedx's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of MiMedx's board members must vote for the resolution. The MiMedx board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Bruce Hack | Independent Director | Profile | |
| Joseph Bleser | Independent Director | Profile | |
| Larry Papasan | Independent Director | Profile | |
| Richard Barry | Director | Profile |
Already Invested in MiMedx Group?
The danger of trading MiMedx Group is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of MiMedx is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than MiMedx. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile MiMedx Group is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MiMedx Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is MiMedx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4 | Earnings Share 0.43 | Revenue Per Share 2.76 | Quarterly Revenue Growth 0.167 | Return On Assets 0.113 |
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.